DE60138739D1 - Supermolekulare carboplatinderivate, deren herstellung und pharmazeutische zusammensetzungen, die diese als wirkstoffe enthalten, sowie anwendungen der zusammensetzungen - Google Patents
Supermolekulare carboplatinderivate, deren herstellung und pharmazeutische zusammensetzungen, die diese als wirkstoffe enthalten, sowie anwendungen der zusammensetzungenInfo
- Publication number
- DE60138739D1 DE60138739D1 DE60138739T DE60138739T DE60138739D1 DE 60138739 D1 DE60138739 D1 DE 60138739D1 DE 60138739 T DE60138739 T DE 60138739T DE 60138739 T DE60138739 T DE 60138739T DE 60138739 D1 DE60138739 D1 DE 60138739D1
- Authority
- DE
- Germany
- Prior art keywords
- derivatives
- carboplatin
- present
- pharmaceutical compositions
- same
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 190000008236 CARBOPLATIN DERIVATIVES Chemical class 0.000 title abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 239000013543 active substance Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 229960004562 carboplatin Drugs 0.000 abstract 2
- 206010073071 hepatocellular carcinoma Diseases 0.000 abstract 2
- 201000004384 Alopecia Diseases 0.000 abstract 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 abstract 1
- 208000005718 Stomach Neoplasms Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 abstract 1
- 238000011047 acute toxicity test Methods 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 230000037396 body weight Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 230000007423 decrease Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 206010017758 gastric cancer Diseases 0.000 abstract 1
- 230000003676 hair loss Effects 0.000 abstract 1
- 238000007912 intraperitoneal administration Methods 0.000 abstract 1
- 231100000636 lethal dose Toxicity 0.000 abstract 1
- 201000005202 lung cancer Diseases 0.000 abstract 1
- 208000020816 lung neoplasm Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229940026778 other chemotherapeutics in atc Drugs 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 201000011549 stomach cancer Diseases 0.000 abstract 1
- 238000007920 subcutaneous administration Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 210000004916 vomit Anatomy 0.000 abstract 1
- 230000008673 vomiting Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0086—Platinum compounds
- C07F15/0093—Platinum compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2001/001595 WO2003045962A1 (fr) | 2001-11-30 | 2001-11-30 | Derives de carboplatine supramoleculaires, leur preparation, compositions pharmaceutiques les contenant comme ingredient actif et utilisations de ces compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60138739D1 true DE60138739D1 (de) | 2009-06-25 |
Family
ID=4574900
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60138739T Expired - Lifetime DE60138739D1 (de) | 2001-11-30 | 2001-11-30 | Supermolekulare carboplatinderivate, deren herstellung und pharmazeutische zusammensetzungen, die diese als wirkstoffe enthalten, sowie anwendungen der zusammensetzungen |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7259270B2 (de) |
| EP (1) | EP1473298B1 (de) |
| JP (1) | JP4235111B2 (de) |
| CN (1) | CN100445293C (de) |
| AT (1) | ATE431352T1 (de) |
| AU (1) | AU2002221514A1 (de) |
| DE (1) | DE60138739D1 (de) |
| WO (1) | WO2003045962A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102432526B1 (ko) * | 2015-04-10 | 2022-08-12 | 신-낫 프로덕츠 엔터프라이즈 엘엘씨 | 디시클로플라틴의 제조방법 |
| BR112017024727A2 (pt) | 2015-05-18 | 2018-07-31 | Syn Nat Products Entpr Llc | cocristal, composição farmacêutica, método de tratamento de uma doença em um indivíduo e processo de produção de um cocristal |
| AU2016279099B2 (en) * | 2015-06-19 | 2021-09-23 | Syn-Nat Products Enterprise LLC | Pharmaceutical composition of carboplatin based co-crystals and use thereof |
| WO2016205782A1 (en) | 2015-06-19 | 2016-12-22 | Syn-Nat Products Enterprise LLC | Composition containing carboplatin and use |
| AU2016284816B2 (en) * | 2015-06-25 | 2021-10-07 | Syn-Nat Products Enterprise LLC | Pharmaceutical co-crystal composition and use thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5455270A (en) * | 1993-08-11 | 1995-10-03 | Bristol-Myers Squibb Co. | Stabilized solutions of platinum(II) antitumor agents |
| CN1121380C (zh) * | 2000-03-03 | 2003-09-17 | 北京兴大豪斯科技有限公司 | 一种抗肿瘤的双二羧酸二氨络铂衍生物及其药物组合物 |
-
2001
- 2001-11-30 WO PCT/CN2001/001595 patent/WO2003045962A1/zh active Application Filing
- 2001-11-30 JP JP2003547411A patent/JP4235111B2/ja not_active Expired - Fee Related
- 2001-11-30 AU AU2002221514A patent/AU2002221514A1/en not_active Abandoned
- 2001-11-30 AT AT01274809T patent/ATE431352T1/de not_active IP Right Cessation
- 2001-11-30 DE DE60138739T patent/DE60138739D1/de not_active Expired - Lifetime
- 2001-11-30 CN CNB018238483A patent/CN100445293C/zh not_active Expired - Fee Related
- 2001-11-30 US US10/497,081 patent/US7259270B2/en not_active Expired - Fee Related
- 2001-11-30 EP EP01274809A patent/EP1473298B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1473298A4 (de) | 2007-11-28 |
| EP1473298A1 (de) | 2004-11-03 |
| JP4235111B2 (ja) | 2009-03-11 |
| JP2005515195A (ja) | 2005-05-26 |
| ATE431352T1 (de) | 2009-05-15 |
| AU2002221514A1 (en) | 2003-06-10 |
| CN1558909A (zh) | 2004-12-29 |
| US7259270B2 (en) | 2007-08-21 |
| CN100445293C (zh) | 2008-12-24 |
| EP1473298B1 (de) | 2009-05-13 |
| US20050165093A1 (en) | 2005-07-28 |
| WO2003045962A1 (fr) | 2003-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE288443T1 (de) | Neue pyrazin-derivate oder salze davon, pharmazeutische zusammensetzungen, die die derivate oder deren salze enthalten und intermediate zu beider herstellung | |
| YU69991A (sh) | Derivati piridina | |
| CY1110395T1 (el) | Αλατα προσθηκης οξεος παραγωγων υδροπυριδινης | |
| ATE152113T1 (de) | Vanadium komplexe, ihre herstellung und pharmazeutische zusammensetzungen, die sie enthalten | |
| ES2094218T3 (es) | Derivados de 2-nitroimidazol, su fabricacion, y agente radiosensibilizante que lo incluye como principio activo. | |
| TR200000223T2 (tr) | XA faktörünü engelleyen heterosiklik türevler | |
| DE69921994D1 (de) | Heterozyklische verbindungen mit faktor xa hemmender wirkung | |
| DE60138739D1 (de) | Supermolekulare carboplatinderivate, deren herstellung und pharmazeutische zusammensetzungen, die diese als wirkstoffe enthalten, sowie anwendungen der zusammensetzungen | |
| NZ232929A (en) | Tungsten compounds containing a lanthanide ion and their use in antiviral compositions | |
| ATE287874T1 (de) | Heterozyklische verbindungen mit faktor xa hemmender wirkung | |
| SE0002476D0 (sv) | New compounds | |
| DE3882679D1 (de) | Kardiovaskulaer aktive verbindungen. | |
| US5116949A (en) | Benzoyl urea compound-albumin complex | |
| MX2022016263A (es) | Derivados de ciclobutil-urea. | |
| KR870006043A (ko) | 피라진유도체 그 제조방법 및 약제조성물 | |
| LV11542B (en) | Substituted 1,3,9,11-tetraoxa-4,5,7,8-tetraazaundecadien-4,7-dioxides-5,7, preparation and use thereof | |
| BR0206311A (pt) | Composto, composição farmacêutica, e, utilização de um composto | |
| ATE325109T1 (de) | Benzofuranderivate und pharmazeutische zusammensetzungen, die diese enthalten | |
| Kovacic et al. | Anticancer quinones and quinolines: mode of action via electron transfer and oxidative stress | |
| Khan et al. | Mixed ligand complexes of cis-dichloromethionineplatinum (II) and cis-dichloromethioninepalladium (II) with substituted pyrimidines | |
| DE60124581D1 (de) | Triazoloä4,5-düpyrimidinderivate als antithrombotische verbindungen | |
| US1280127A (en) | Arsenical compound. | |
| Sakurai et al. | Bacteriostatic activity of the nitrogen mustard N-oxides against Escherichia coli | |
| TH50173A (th) | การใช้ 1-ไฮดรอกซี-2-ไพริโดนสำหรับการบำบัดการติดเชื้อที่ผิวหนัง | |
| TH13944A (th) | สารประกอบเฮเทโรไซคลิค |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |